Biotech & pharma news, stocks, science, startups
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 168 | Founded | 2 years ago | Last Issue | 10 days ago |
| Active | |||||
Read this Newsletter
biotechblueprint.comLatest Issues
The best small cell lung cancer data in 30 years, and the argument over whether to believe It – This Week in Biotech #118
Welcome back to This Week in Biotech by Biotech Blueprint, edition 118, covering biotech and pharma news from September 11th to 17th, 2026.
🎙️ Biotech Blueprint brings you weekly video updates on the latest biotech and pharma news,...
Novartis had the worst day in its history and the FDA approved a drug its advisers rejected, again – This Week in Biotech #117
Welcome back to This Week in Biotech by Biotech Blueprint, edition 117, covering biotech and pharma news from September 4th to 10th, 2026.
🎙️ Biotech Blueprint brings you weekly video updates on the latest biotech and pharma news,...
FDA official overruled her own review team to approve Replimune’s drug – This Week in Biotech #116
Welcome back to This Week in Biotech by Biotech Blueprint, edition 116, covering biotech and pharma news from August 28 to September 3, 2026.
Biotech’s next frontier
Genomic medicine is at an inflection point. What comes next h...
FDA Approves a Pancreatic Cancer Drug in 35 Days – This Week in Biotech #115
Welcome back to This Week in Biotech by Biotech Blueprint, edition 115, covering biotech and pharma news from August 21 to 27, 2026.
🎙️ Biotech Blueprint brings you weekly video updates on the latest biotech and pharma news, plus i...
Moderna mRNA cancer vaccine won Phase 3 in melanoma. The numbers come next
Welcome back to Biotech Blueprint!
Hartaj (author of ) and I recorded this episode on August 20, 2026, the day after the Phase 3 INTerpath-001 trial read out, while the stock was still moving. A week later we still don’t have a single num...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Biotech Blueprint.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Johns Hopkins PhD. Subscribe for biotechnology & pharma newsletter and biotech company spotlights.
Biotech Capital Compass breaks down complex biotech stories into valuation, risk, and narrative frameworks investors can use. Written by Hartaj Singh, a biotech analyst focused on translating innovation into investment reality.
Frequently Asked Questions
How can I access the email archive for Biotech Blueprint?
You can find recent issues that have been published by Biotech Blueprint on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Biotech Blueprint have?
To see how many people subscribe to Biotech Blueprint, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Biotech Blueprint?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biotech Blueprint as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Biotech Blueprint?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biotech Blueprint using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Biotech Blueprint?
Scroll up to where it says Related Newsletters to see other publications like Biotech Blueprint. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Biotech Blueprint?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.